E-LIB Suche - Ergebnisse für: Albertini, Mark R.

1

Development of a next-generation sequencing protocol for th..:

Zuleger, Cindy L. ; Schwartz, Rene Welch ; Ong, Irene M....
Veterinary Immunology and Immunopathology. 268 (2024) - p. 110702 , 2024

Link: https://doi.org/10.1016/..

2

Neutrophil‐to‐eosinophil ratio as a biomarker for clinical ..:

Pozorski, Vincent ; Park, Yeonhee ; Mohamoud, Yusuf...
Pigment Cell & Melanoma Research. 36 (2023) 6 - p. 501-511 , 2023

Link: https://doi.org/10.1111/..

3

NK cells propagate T cell immunity following in situ tumor ..:

Jin, Won Jong ; Jagodinsky, Justin C. ; Vera, Jessica M....
Cell Reports. 42 (2023) 12 - p. 113556 , 2023

Link: https://doi.org/10.1016/..

4

Molecular characterization of hypoxanthine guanine phosphor..:

Kaitz, Noah A. ; Zuleger, Cindy L. ; Yu, Peng...
Mutation Research/Reviews in Mutation Research. 789 (2022) - p. 108414 , 2022

Link: https://doi.org/10.1016/..

5

Retrograde Balloon-Assisted Deep Enteroscopy in the Diagnos..:

Barge, William ; Albertini, Mark R. ; Cold, Christopher...
Case Reports in Gastrointestinal Medicine. 2021 (2021) - p. 1-4 , 2021

Link: https://doi.org/10.1155/..

6

Immune adverse events (irAEs) with adjuvant ipilimumab in m..:

Tarhini, Ahmad A ; Kang, Ni ; Lee, Sandra J...
Journal for ImmunoTherapy of Cancer. 9 (2021) 5 - p. e002535 , 2021

Link: https://doi.org/10.1136/..

7

Safety and feasibility of an in situ vaccination and immuno..:

Magee, Kara ; Marsh, Ian R. ; Turek, Michelle M....
PLOS ONE. 16 (2021) 8 - p. e0255798 , 2021

Link: https://doi.org/10.1371/..

8

FDG PET/CT for Assessment of Immune Therapy: Opportunities ..:

Cho, Steve Y. ; Huff, Daniel T. ; Jeraj, Robert.
Seminars in Nuclear Medicine. 50 (2020) 6 - p. 518-531 , 2020

Link: https://doi.org/10.1053/..

9

Pilot trial of the hu14.18-IL2 immunocytokine in patients w..:

Albertini, Mark R. ; Yang, Richard K. ; Ranheim, Erik A....
Cancer Immunology, Immunotherapy. 67 (2018) 10 - p. 1647-1658 , 2018

Link: https://doi.org/10.1007/..

10

The age of enlightenment in melanoma immunotherapy:

Albertini, Mark R.
Journal for ImmunoTherapy of Cancer. 6 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

11

Chemoprevention agents for melanoma: A path forward into ph..:

Jeter, Joanne M. ; Bowles, Tawnya L. ; Curiel‐Lewandrowski, Clara...
Cancer. 125 (2018) 1 - p. 18-44 , 2018

Link: https://doi.org/10.1002/..

12

Pilot study of safety and feasibility of DNA microseeding f..:

Zuleger, Cindy L. ; Kang, Chulhi ; Ranheim, Erik A....
Veterinary Medicine and Science. 3 (2017) 3 - p. 134-145 , 2017

Link: https://doi.org/10.1002/..

13

Relationship between physician-adjudicated adverse events a..:

Atkinson, Thomas M. ; Hay, Jennifer L. ; Shoushtari, Alexander...
Journal of Cancer Research and Clinical Oncology. 143 (2016) 3 - p. 439-445 , 2016

Link: https://doi.org/10.1007/..

14

Phase I study to evaluate toxicity and feasibility of intra..:

Albertini, Mark R. ; Ranheim, Erik A. ; Zuleger, Cindy L....
Cancer Immunology, Immunotherapy. 65 (2016) 8 - p. 897-907 , 2016

Link: https://doi.org/10.1007/..

15

OMIP‐008: Measurement of Th1 and Th2 cytokine polyfunctiona..:

Zuleger, Cindy L. ; Albertini, Mark R.
Cytometry Part A. 81A (2012) 6 - p. 450-452 , 2012

Link: https://doi.org/10.1002/..